Semaglutide reduces severity of common liver disease in people with HIV
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy Multi-country findings…
More than half of American Indian youth may have abnormal or high cholesterol NIH-funded study…
Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed…
Children surpass a year of HIV remission after treatment pause NIH-funded trial shows promising outcomes…
For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life NIH-led…
Topical solution halts tooth decay in children NIH-funded study finds non-invasive application of silver diamine…
NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction Part of…
Delta-8-THC use reported by 11% of 12th graders in 2023 Use of the psychoactive cannabis…
NIH scientists find weak points on Epstein-Barr virus New details of EBV protein could aid…